A comparison of hypolipidemic drugs in the prevention of an orotic acid fatty liver.
D000818:Animals; D002994:Clofibrate / Q000494:pharmacology; D004032:Diet; D004586:Electrophoresis; D005021:Ethylamines / Q000494:pharmacology; D005234:Fatty Liver / Q000139:chemically induced / Q000517:prevention & control*; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism; D006529:Hepatomegaly / Q000517:prevention & control; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D008074:Lipoproteins / Q000097:blood; D008099:Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D008297:Male; D008744:Methylamines / Q000494:pharmacology; D009281:Naphthalenes / Q000494:pharmacology; D009963:Orotic Acid / Q000037:antagonists & inhibitors*; D010636:Phenols / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D011422:Propionates / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D013449:Sulfonamides / Q000494:pharmacology; D013451:Sulfonic Acids / Q000494:pharmacology; D013974:Thyroxine / Q000494:pharmacology
D005021:Ethylamines; D000960:Hypolipidemic Agents; D008074:Lipoproteins; D008744:Methylamines; D009281:Naphthalenes; D010636:Phenols; D010880:Piperidines; D011422:Propionates; D013449:Sulfonamides; D013451:Sulfonic Acids; D009963:Orotic Acid; D005954:Glucosephosphate Dehydrogenase; D002994:Clofibrate; D013974:Thyroxine